Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).

被引：0
|
作者：
Spanu, A
Schillaci, O
Falchi, A
Marongiu, P
Pisu, N
Madeddu, G
Solinas, ME
Solinas, P
Scopinaro, F
Madeddu, G
机构：
[1] Univ Sassari, I-07100 Sassari, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Roma La Sapienza, Rome, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1206
引用
收藏
页码：299P / 299P
页数：1
相关论文
共 50 条
  • [31] Role of somatostatin receptor scintigraphy with indium 111-pentetreotide in gastroenteropancreatic endocrine tumours.
    Lebtahi, R
    Cadiot, G
    Mignon, M
    LeGuludec, D
    MEDECINE NUCLEAIRE, 1996, 20 (4-5): : 304 - 308
  • [32] Role of Somatostatin Immunohistochemistry in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Tumours
    O'Connor, R.
    Ryan, C.
    Tamagno, G.
    O'Shea, D.
    O'Toole, D.
    Geoghegan, J.
    Swan, N.
    JOURNAL OF PATHOLOGY, 2017, 243 : S39 - S39
  • [33] Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors
    Ezziddin, S
    Logvinski, T
    Yong-Hing, C
    Ahmadzadehfar, H
    Fischer, HP
    Palmedo, H
    Bucerius, J
    Reinhardt, MJ
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (02) : 223 - 233
  • [34] Somatostatin receptor scintigraphy (SRS), a new method to distinguish hepatic hemangiomas from vascular liver metastases in pancreatic endocrine tumors (PET).
    Termanini, B
    Gibril, F
    Doppman, JH
    Stewart, CA
    Sutliff, VE
    Jensen, RT
    GASTROENTEROLOGY, 1996, 110 (04) : A437 - A437
  • [35] Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors
    Schillaci, O
    Spanu, A
    Scopinaro, F
    Falchi, A
    Corleto, V
    Danieli, R
    Marongiu, P
    Pisu, N
    Madeddu, G
    Delle Fave, G
    Madeddu, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (06) : 1687 - 1695
  • [36] SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN NEUROENDOCRINE NEOPLASMS
    ANTHONY, LB
    MARTIN, W
    ARILDSEN, R
    SHAFF, M
    CLANTON, J
    DELBEKE, D
    SANDLER, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 174 - 174
  • [37] Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors - Discussion
    Shaha, AR
    Frilling, A
    Moore, FD
    Proye, C
    SURGERY, 1998, 124 (06) : 1004 - 1004
  • [38] Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases
    Nakamura, Shoko
    Tomisato, Kota
    Teramoto, Akira
    Kondo, Akiyuki
    Matsukawa, Shinobu
    Yabutani, Akira
    Iraha, Atsushi
    Kobashikawa, Kasen
    Nakamura, Masamoto
    Nakayoshi, Tomokuni
    Uchima, Nobufumi
    Kinjo, Fukunori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 258 - 258
  • [39] Somatostatin receptor scintigraphy (SSRS) in GEP-tumors
    Krenning, EP
    Kwekkeboom, DJ
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1229 - 1229
  • [40] Somatostatin receptor scintigraphy (SRS) in the surgical management of patients with gastro-entero-pancreatic endocrine (GEP) tumor
    Angeletti, S
    Moretti, A
    Corleto, VD
    Schillaci, O
    Martino, G
    Marignani, M
    Annibale, B
    Scopinaro, F
    Bordi, C
    Basso, N
    DelleFave, G
    GASTROENTEROLOGY, 1997, 112 (04) : A426 - A426
12345